Patent for HCS
High Content Screening company Cellomics announced today that the Canadian Intellectual Property Office has issued Cellomics' Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based Screening.'
Archives for February 3, 2003
Genetronics approves BTX sale
Genetronics Biomedical has completed the sale its BTX division to Harvard Bioscience for $3.7 million. Genetronics Biomedical's stockholders approved the sale in a meeting on Friday.
Degussa takeover cleared
The takeover bid from mining and technology group RAG for Germany's speciality chemicals company Degussa is to go ahead according to the company.